An international consortium of aging researchers has developed a system combining advanced wearable biosensors with artificial intelligence to continuously monitor key biomarkers — including inflammatory markers, metabolic flexibility, and DNA methylation patterns. Machine-learning algorithms analyze these real-time data streams to predict biological age and guide personalized interventions aimed at extending human healthspan.
Key points
- Graphene-based wearable biosensors continuously track inflammatory markers, metabolic flexibility, and epigenetic signals.
- AI-driven machine-learning models analyze multi-biomarker data streams to predict biological age with 90% accuracy.
- Closed-loop intervention protocols leverage real-time epigenetic and metabolic feedback to reverse biological age by up to 5 years within weeks.
Why it matters: This convergence of wearable biosensors and AI-driven analytics marks a paradigm shift from reactive healthcare to proactive, data-driven longevity management, enabling early intervention to prevent cellular damage and extend healthy lifespan.
Q&A
- What are aging biomarkers?
- How does continuous monitoring differ from annual checkups?
- What is metabolic flexibility?
- How does AI predict biological age?